Proactive Planning Opens the Door to Effective Lifecycle Management

RESEARCH TRIANGLE PARK, NC, Apr 10 (MARKET WIRE) --
According to a new study released by Cutting Edge Information, the most
successful lifecycle management (LCM) programs are those that begin planning at
the
start of a drug's development. The report, "Pharma Brand Optimization:
LifecycleManagement Strategy," explores the value of proactive planning
(http://www.PharmaLifecycleManagement.com).

The report finds that proactive planning is one of the most important
factors in
effective LCM programs, second only to winning senior management buy-in. Too
many
companies wait to start their LCM processes until Phase III or later in a
product's lifecycle. In doing so, they miss out on opportunities to
establish strong patents and competitive labels. Companies that begin their LCM
planning earlier have a competitive edge over those that wait until ramp-up to
product launch.

"Starting LCM planning during a drug's pre-clinical phase gives a company an
outline that can evolve as the brand evolves," says Elio Evangelista, research
team
leader at Cutting Edge Information. "This outline is necessary because it
gives the brand direction in its development."

Companies that put LCM plans in place early give themselves the
opportunityto predict possible outcomes in the brand's future, which enables a
smoother development. On the other hand, companies that wait until Phase III
are not proactive and must spend time and resources reacting to outcomes as
they watch their competitors' success grow.

"A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy"
(http://www.PharmaLifecycleManagement.com) examines pharmaceutical companies'
lifecycle
management structures, funding, processes, and strategies. It guides readers
through a drug's lifecycle stages, offering insights and recommendations on the
most common lifecycle management strategies for each time period. Each strategy
is
illustrated by relevant industry examples. Through this report, readers will be
better positioned to streamline their LCM strategies and processes by
benchmarking
theirefforts against those of top-leading companies.

Download a free summary of "A Guidebook to Pharma Brand Optimization:
Lifecycle
Management Strategy" or purchase the report at
http://www.cuttingedgeinfo.com/pharmalifecyclemanagement/PH108_Download.asp#body

CONTACT:
Elio Evangelista
Email Contact
919-433-0214

Copyright 2008, Market Wire, All rights reserved.

-0-